Literature DB >> 10493912

Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.

J Ljusberg1, B Ek-Rylander, G Andersson.   

Abstract

Purple acid phosphatases (PAPs) are binuclear acid metallohydrolases also referred to as tartrate-resistant acid phosphatases (TRAPs) or type 5 acid phosphatases. The cDNA sequences of TRAP/PAP enzymes from different species and organs indicate that these enzymes are translated as monomeric polypeptides of approx. 35 kDa, contrasting with the predominantly two-subunit structure observed in purified enzyme preparations. In the present study we have compared certain structural and enzyme-kinetic properties of recombinant rat PAP (monomeric) with those of the native rat bone TRAP/PAP enzyme (two-subunit), and examined effects on these parameters by cleaving the monomeric recombinant PAP with the serine proteinase trypsin or the cysteine proteinases papain or cathepsin B. Cleavage with trypsin resulted in a moderate activation of the recombinant enzyme and shifted the pH optimum to a slightly more basic value (5.0-5.5). Cleavage with papain resulted in complete activation and conferred similar properties to those of the bone PAP variant with regard to pH optimum (5.5-6.0) and sensitivity to reducing agents, as well as in the sizes of the subunits. Substrate specificity studies showed that the two-subunit bone PAP was considerably more active than the monomeric recombinant rat PAP towards a variety of serine-, threonine- and tyrosine-phosphorylated substrates. Of these substrates, bovine milk osteopontin seemed to be the most readily dephosphorylated substrate. In conclusion, the results suggest that the monomeric form of PAP represent a latent proenzyme with low enzymic activity towards both tyrosine- and serine/threonine-containing phosphorylated substrates. Besides being implicated in the catabolism of the extracellular matrix, members of the cysteine proteinase family might also exert a regulatory role in degradative processes involving the PAP enzymes by converting the newly synthesized PAPs to enzymically active and microenvironmentally regulated species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493912      PMCID: PMC1220524     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.

Authors:  C M Ketcham; R M Roberts; R C Simmen; H S Nick
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase.

Authors:  J M Halleen; H Kaija; J J Stepan; P Vihko; H K Väänänen
Journal:  Arch Biochem Biophys       Date:  1998-04-01       Impact factor: 4.013

3.  Tartrate-resistant acid ATPase as a cytochemical marker for osteoclasts.

Authors:  G N Andersson; S C Marks
Journal:  J Histochem Cytochem       Date:  1989-01       Impact factor: 2.479

4.  Sequence homology in the metalloproteins; purple acid phosphatase from beef spleen and uteroferrin from porcine uterus.

Authors:  D F Hunt; J R Yates; J Shabanowitz; N Z Zhu; T Zirino; B A Averill; S T Daurat-Larroque; J G Shewale; R M Roberts; K Brew
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

5.  Histochemical investigations on the localization of the purple acid phosphatase in the bovine spleen.

Authors:  J Schindelmeiser; D Münstermann; H Witzel
Journal:  Histochemistry       Date:  1987

6.  Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix.

Authors:  K H Lau; T K Freeman; D J Baylink
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

7.  A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay.

Authors:  A A Baykov; O A Evtushenko; S M Avaeva
Journal:  Anal Biochem       Date:  1988-06       Impact factor: 3.365

8.  Purification and characterization of a vanadate-sensitive nucleotide tri- and diphosphatase with acid pH optimum from rat bone.

Authors:  G Andersson; B Ek-Rylander; L Hammarström
Journal:  Arch Biochem Biophys       Date:  1984-02-01       Impact factor: 4.013

9.  The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.

Authors:  C M Ketcham; G A Baumbach; F W Bazer; R M Roberts
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

10.  Enzymatically active zinc, copper and mercury derivatives of the one-iron form of pig allantoic fluid acid phosphatase.

Authors:  J L Beck; D T Keough; J De Jersey; B Zerner
Journal:  Biochim Biophys Acta       Date:  1984-12-21
View more
  17 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

2.  Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.

Authors:  Karin Hollberg; Joakim Nordahl; Kjell Hultenby; Silwa Mengarelli-Widholm; Göran Andersson; Finn P Reinholt
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

3.  Direct observation of multiple protonation states in recombinant human purple acid phosphatase.

Authors:  Enrico G Funhoff; Thyra E de Jongh; Bruce A Averill
Journal:  J Biol Inorg Chem       Date:  2005-09-23       Impact factor: 3.358

4.  Analysis of substrate specificity and endopeptidyl activities of the cathepsin B-like proteinase from Helicoverpa armigera.

Authors:  Xiao-Fan Zhao; Jin-Xing Wang; Fei-Xue Li; Shinji Sueda; Hiroki Kondo
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

5.  A new heterobinuclear FeIIICuII complex with a single terminal FeIII-O(phenolate) bond. Relevance to purple acid phosphatases and nucleases.

Authors:  Mauricio Lanznaster; Ademir Neves; Adailton J Bortoluzzi; Veronika V E Aires; Bruno Szpoganicz; Hernán Terenzi; Patricia Cardoso Severino; Julie M Fuller; Simon C Drew; Lawrence R Gahan; Graeme R Hanson; Mark J Riley; Gerhard Schenk
Journal:  J Biol Inorg Chem       Date:  2005-04-21       Impact factor: 3.358

6.  Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo.

Authors:  A R Hayman; A J Bune; T M Cox
Journal:  J Anat       Date:  2000-04       Impact factor: 2.610

7.  Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.

Authors:  Serhan Zenger; Wentao He; Barbro Ek-Rylander; Daphne Vassiliou; Rickard Wedin; Henrik Bauer; Göran Andersson
Journal:  Clin Exp Metastasis       Date:  2010-10-22       Impact factor: 5.150

8.  Evaluation of bone remodeling in regard to the age of scaphoid non-unions.

Authors:  Susanne Rein; Uwe Hanisch; Hans-Eberhard Schaller; Hans Zwipp; Stefan Rammelt; Stefan Weindel
Journal:  World J Orthop       Date:  2016-07-18

9.  The crystal structure of Arabidopsis VSP1 reveals the plant class C-like phosphatase structure of the DDDD superfamily of phosphohydrolases.

Authors:  Yuhong Chen; Jia Wei; Mingzhu Wang; Zhubing Shi; Weimin Gong; Min Zhang
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.

Authors:  Siddaraju M Nanjundaiah; Brian Astry; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.